Julie Jordan Insider Profile
11 Followers
Julie Jordan, CMO at Neurogene, holds 12.47K shares in Neurogene (Ticker: NGNE), holds 7.50K shares in Q32 Bio (Ticker: QTTB). Most recently, Julie Jordan Sold ― shares of Neurogene on Mar 30, 2026 for an estimated value of $18.12K.
Julie Jordan has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Julie Jordan
Julie Jordan's Trading History
Neurogene
Mar 30, 2026
CMO
Informative Sell
18.12K
$442.51K
Q32 Bio
Aug 07, 2023
CMO
Uninformative Buy
6.57K
$83.21K
List of latest transactions for each holding click on a transaction to see Julie Jordan's performance on stock
You May Also Like
Julie Jordan insider profile FAQ
What is the percentage of profitable transactions made by Julie Jordan?
The percentage of profitable transactions made by Julie Jordan is ―.
What is the average return per transaction made by Julie Jordan?
The average return per transaction made by Julie Jordan is ―.
What stocks does Julie Jordan hold?
Julie Jordan holds: NGNE, QTTB stocks.
What was Julie Jordan’s latest transaction?
Julie Jordan latest transaction was an Informative Sell of $18.12K.
What was Julie Jordan's most profitable transaction?
Julie Jordan’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Julie Jordan's role in Neurogene?
Julie Jordan's role in Neurogene is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.